avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSMUSG00000005677.8 | nuclear receptor subfamily 1, group I, member 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1i3 | mm10_v2_chr1_+_171214013_171214045 | 0.65 | 1.6e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_34355383 | 18.76 |
ENSMUST00000052126.5
|
Fam25c
|
family with sequence similarity 25, member C |
chr4_-_60582152 | 15.69 |
ENSMUST00000098047.2
|
Mup10
|
major urinary protein 10 |
chr17_-_32917048 | 14.09 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr5_-_146009598 | 13.59 |
ENSMUST00000138870.1
ENSMUST00000068317.6 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr4_-_61674094 | 13.55 |
ENSMUST00000098040.3
|
Mup18
|
major urinary protein 18 |
chr4_-_60662358 | 13.49 |
ENSMUST00000084544.4
ENSMUST00000098046.3 |
Mup11
|
major urinary protein 11 |
chr19_+_39007019 | 13.47 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr4_-_60222580 | 13.12 |
ENSMUST00000095058.4
ENSMUST00000163931.1 |
Mup8
|
major urinary protein 8 |
chr4_-_61303998 | 12.63 |
ENSMUST00000071005.8
ENSMUST00000075206.5 |
Mup14
|
major urinary protein 14 |
chr9_+_46268601 | 12.32 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chr17_-_32917320 | 11.84 |
ENSMUST00000179434.1
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr4_+_115518264 | 11.79 |
ENSMUST00000058785.3
ENSMUST00000094886.3 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr7_+_27119909 | 11.43 |
ENSMUST00000003100.8
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr17_-_31144271 | 10.88 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr1_+_166254095 | 10.67 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr4_+_63344548 | 10.30 |
ENSMUST00000030044.2
|
Orm1
|
orosomucoid 1 |
chr4_-_62087261 | 10.29 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr6_+_41302265 | 10.19 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr4_-_60421933 | 10.10 |
ENSMUST00000107506.2
ENSMUST00000122381.1 ENSMUST00000118759.1 ENSMUST00000122177.1 |
Mup9
|
major urinary protein 9 |
chr8_+_105083753 | 9.87 |
ENSMUST00000093221.6
ENSMUST00000074403.6 |
Ces3b
|
carboxylesterase 3B |
chr15_-_60921270 | 9.80 |
ENSMUST00000096418.3
|
A1bg
|
alpha-1-B glycoprotein |
chr19_-_8405060 | 9.53 |
ENSMUST00000064507.5
ENSMUST00000120540.1 ENSMUST00000096269.4 |
Slc22a30
|
solute carrier family 22, member 30 |
chr19_-_7802578 | 9.46 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr7_+_26808880 | 9.37 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr1_+_72824482 | 9.31 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr4_+_63362443 | 9.28 |
ENSMUST00000075341.3
|
Orm2
|
orosomucoid 2 |
chr4_-_61835185 | 9.00 |
ENSMUST00000082287.2
|
Mup5
|
major urinary protein 5 |
chr4_+_115299046 | 8.86 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr8_+_104926237 | 8.63 |
ENSMUST00000034355.4
ENSMUST00000109410.2 |
Ces2e
|
carboxylesterase 2E |
chr17_+_84683113 | 8.62 |
ENSMUST00000045714.8
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr10_+_79890853 | 8.61 |
ENSMUST00000061653.7
|
Cfd
|
complement factor D (adipsin) |
chr4_-_61303802 | 8.54 |
ENSMUST00000125461.1
|
Mup14
|
major urinary protein 14 |
chr4_-_60139857 | 8.49 |
ENSMUST00000107490.4
ENSMUST00000074700.2 |
Mup2
|
major urinary protein 2 |
chr9_-_46235260 | 8.23 |
ENSMUST00000121916.1
ENSMUST00000034586.2 |
Apoc3
|
apolipoprotein C-III |
chr17_+_84683131 | 8.04 |
ENSMUST00000171915.1
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr19_+_12633303 | 7.75 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr4_-_62054112 | 7.75 |
ENSMUST00000074018.3
|
Mup20
|
major urinary protein 20 |
chr6_-_85869128 | 7.69 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr4_+_115411624 | 7.67 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr16_+_91269759 | 7.55 |
ENSMUST00000056882.5
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr3_-_98630309 | 7.49 |
ENSMUST00000044094.4
|
Hsd3b5
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 |
chr19_-_8131982 | 7.39 |
ENSMUST00000065651.4
|
Slc22a28
|
solute carrier family 22, member 28 |
chr2_-_25469742 | 7.39 |
ENSMUST00000114259.2
ENSMUST00000015234.6 |
Ptgds
|
prostaglandin D2 synthase (brain) |
chr4_+_115600975 | 7.00 |
ENSMUST00000084342.5
|
Cyp4a32
|
cytochrome P450, family 4, subfamily a, polypeptide 32 |
chr9_+_46269069 | 6.97 |
ENSMUST00000034584.3
|
Apoa5
|
apolipoprotein A-V |
chr5_-_145879857 | 6.97 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr6_-_138073196 | 6.83 |
ENSMUST00000050132.3
|
Slc15a5
|
solute carrier family 15, member 5 |
chr14_+_69171576 | 6.83 |
ENSMUST00000062437.8
|
Nkx2-6
|
NK2 homeobox 6 |
chr7_+_25897620 | 6.81 |
ENSMUST00000072438.6
ENSMUST00000005477.5 |
Cyp2b10
|
cytochrome P450, family 2, subfamily b, polypeptide 10 |
chr11_-_70514608 | 6.78 |
ENSMUST00000021179.3
|
Vmo1
|
vitelline membrane outer layer 1 homolog (chicken) |
chr10_+_128254131 | 6.58 |
ENSMUST00000060782.3
|
Apon
|
apolipoprotein N |
chr9_-_48605147 | 6.58 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr3_-_107969162 | 6.57 |
ENSMUST00000004136.8
ENSMUST00000106678.1 |
Gstm3
|
glutathione S-transferase, mu 3 |
chr15_+_10314102 | 6.57 |
ENSMUST00000127467.1
|
Prlr
|
prolactin receptor |
chr10_+_127801145 | 6.52 |
ENSMUST00000071646.1
|
Rdh16
|
retinol dehydrogenase 16 |
chr11_-_26210553 | 6.51 |
ENSMUST00000101447.3
|
5730522E02Rik
|
RIKEN cDNA 5730522E02 gene |
chr10_+_127866457 | 6.50 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr4_-_63154130 | 6.44 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr11_-_113708952 | 6.43 |
ENSMUST00000106617.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr15_+_10223974 | 6.39 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr17_-_84682932 | 6.24 |
ENSMUST00000066175.3
|
Abcg5
|
ATP-binding cassette, sub-family G (WHITE), member 5 |
chr1_-_130661584 | 6.18 |
ENSMUST00000137276.2
|
C4bp
|
complement component 4 binding protein |
chr1_-_130661613 | 6.16 |
ENSMUST00000027657.7
|
C4bp
|
complement component 4 binding protein |
chr4_-_42756543 | 6.10 |
ENSMUST00000102957.3
|
Ccl19
|
chemokine (C-C motif) ligand 19 |
chr4_-_59960659 | 6.07 |
ENSMUST00000075973.2
|
Mup4
|
major urinary protein 4 |
chr6_-_5256226 | 6.01 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr2_+_102706356 | 5.98 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr10_+_87859481 | 5.97 |
ENSMUST00000121952.1
|
Igf1
|
insulin-like growth factor 1 |
chr7_-_141276729 | 5.95 |
ENSMUST00000167263.1
ENSMUST00000080654.5 |
Cdhr5
|
cadherin-related family member 5 |
chr11_+_72435565 | 5.85 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr10_+_87859593 | 5.83 |
ENSMUST00000126490.1
|
Igf1
|
insulin-like growth factor 1 |
chr7_-_99695809 | 5.79 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr6_+_90550789 | 5.79 |
ENSMUST00000130418.1
ENSMUST00000032175.8 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr3_-_18243289 | 5.76 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr6_+_90333270 | 5.75 |
ENSMUST00000164761.1
ENSMUST00000046128.9 |
Uroc1
|
urocanase domain containing 1 |
chr10_-_24101951 | 5.72 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr17_-_78985428 | 5.70 |
ENSMUST00000118991.1
|
Prkd3
|
protein kinase D3 |
chr4_-_62150810 | 5.68 |
ENSMUST00000077719.3
|
Mup21
|
major urinary protein 21 |
chr2_+_173153048 | 5.63 |
ENSMUST00000029017.5
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr9_-_65422773 | 5.56 |
ENSMUST00000065894.5
|
Slc51b
|
solute carrier family 51, beta subunit |
chr1_-_140183404 | 5.53 |
ENSMUST00000066859.6
ENSMUST00000111976.2 |
Cfh
|
complement component factor h |
chr11_+_70054334 | 5.50 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr1_-_139781236 | 5.47 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
Gm4788
|
predicted gene 4788 |
chr10_+_87521920 | 5.47 |
ENSMUST00000142088.1
|
Pah
|
phenylalanine hydroxylase |
chr9_-_57683644 | 5.46 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr9_-_46235631 | 5.41 |
ENSMUST00000118649.1
|
Apoc3
|
apolipoprotein C-III |
chr4_+_60003438 | 5.41 |
ENSMUST00000107517.1
ENSMUST00000107520.1 |
Mup6
|
major urinary protein 6 |
chr17_+_24878724 | 5.39 |
ENSMUST00000050714.6
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr1_-_139560158 | 5.38 |
ENSMUST00000160423.1
ENSMUST00000023965.5 |
Cfhr1
|
complement factor H-related 1 |
chr7_-_105600103 | 5.35 |
ENSMUST00000033185.8
|
Hpx
|
hemopexin |
chr8_+_105048592 | 5.35 |
ENSMUST00000093222.5
ENSMUST00000093223.3 |
Ces3a
|
carboxylesterase 3A |
chr4_-_60741275 | 5.34 |
ENSMUST00000117932.1
|
Mup12
|
major urinary protein 12 |
chr19_-_11081088 | 5.34 |
ENSMUST00000025636.6
|
Ms4a8a
|
membrane-spanning 4-domains, subfamily A, member 8A |
chr1_-_140183283 | 5.33 |
ENSMUST00000111977.1
|
Cfh
|
complement component factor h |
chr12_+_112106683 | 5.31 |
ENSMUST00000079400.4
|
Aspg
|
asparaginase homolog (S. cerevisiae) |
chr9_+_46240696 | 5.31 |
ENSMUST00000034585.6
|
Apoa4
|
apolipoprotein A-IV |
chr1_-_180193653 | 5.29 |
ENSMUST00000159914.1
|
Adck3
|
aarF domain containing kinase 3 |
chr5_-_137921612 | 5.25 |
ENSMUST00000031741.7
|
Cyp3a13
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
chr9_-_15301555 | 5.24 |
ENSMUST00000034414.8
|
4931406C07Rik
|
RIKEN cDNA 4931406C07 gene |
chr4_-_19922599 | 5.23 |
ENSMUST00000029900.5
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr10_+_87521795 | 5.22 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr1_+_131797381 | 5.21 |
ENSMUST00000112393.2
ENSMUST00000048660.5 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr5_+_146079254 | 5.14 |
ENSMUST00000035571.8
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr4_+_42629719 | 5.10 |
ENSMUST00000166898.2
|
Gm2564
|
predicted gene 2564 |
chr1_+_78511865 | 5.02 |
ENSMUST00000012331.6
|
Mogat1
|
monoacylglycerol O-acyltransferase 1 |
chr5_-_116422858 | 4.98 |
ENSMUST00000036991.4
|
Hspb8
|
heat shock protein 8 |
chr15_+_99393610 | 4.95 |
ENSMUST00000159531.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr16_-_18413452 | 4.94 |
ENSMUST00000165430.1
ENSMUST00000147720.1 |
Comt
|
catechol-O-methyltransferase |
chr6_-_138079916 | 4.94 |
ENSMUST00000171804.1
|
Slc15a5
|
solute carrier family 15, member 5 |
chr8_+_104867488 | 4.92 |
ENSMUST00000043209.9
|
Ces2d-ps
|
carboxylesterase 2D, pseudogene |
chr8_+_104847061 | 4.89 |
ENSMUST00000055052.5
|
Ces2c
|
carboxylesterase 2C |
chr10_+_87860030 | 4.87 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr7_-_30973464 | 4.87 |
ENSMUST00000001279.8
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr15_+_99393574 | 4.84 |
ENSMUST00000162624.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr18_+_45268876 | 4.82 |
ENSMUST00000183850.1
ENSMUST00000066890.7 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr15_+_100353149 | 4.82 |
ENSMUST00000075675.5
ENSMUST00000088142.5 ENSMUST00000176287.1 |
AB099516
Mettl7a2
|
cDNA sequence AB099516 methyltransferase like 7A2 |
chr2_+_122147680 | 4.82 |
ENSMUST00000102476.4
|
B2m
|
beta-2 microglobulin |
chr10_-_127370535 | 4.77 |
ENSMUST00000026472.8
|
Inhbc
|
inhibin beta-C |
chr19_+_20601958 | 4.76 |
ENSMUST00000087638.3
|
Aldh1a1
|
aldehyde dehydrogenase family 1, subfamily A1 |
chr1_-_180193475 | 4.72 |
ENSMUST00000160482.1
ENSMUST00000170472.1 |
Adck3
|
aarF domain containing kinase 3 |
chr5_-_87337165 | 4.69 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr10_-_109010955 | 4.66 |
ENSMUST00000105276.1
ENSMUST00000064054.7 |
Syt1
|
synaptotagmin I |
chr13_+_24845122 | 4.66 |
ENSMUST00000006893.8
|
D130043K22Rik
|
RIKEN cDNA D130043K22 gene |
chr13_+_4436094 | 4.65 |
ENSMUST00000156277.1
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr2_-_25501717 | 4.64 |
ENSMUST00000015227.3
|
C8g
|
complement component 8, gamma polypeptide |
chr2_+_71981184 | 4.61 |
ENSMUST00000090826.5
ENSMUST00000102698.3 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr7_-_48848023 | 4.57 |
ENSMUST00000032658.6
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr11_+_72435511 | 4.55 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr1_+_87264345 | 4.52 |
ENSMUST00000118687.1
ENSMUST00000027472.6 |
Efhd1
|
EF hand domain containing 1 |
chr8_+_104733997 | 4.47 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr7_+_13623967 | 4.47 |
ENSMUST00000108525.2
|
Sult2a5
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 5 |
chr7_+_44225430 | 4.41 |
ENSMUST00000075162.3
|
Klk1
|
kallikrein 1 |
chr15_-_89373810 | 4.39 |
ENSMUST00000167643.2
|
Sco2
|
SCO cytochrome oxidase deficient homolog 2 (yeast) |
chr14_+_66140919 | 4.39 |
ENSMUST00000022620.9
|
Chrna2
|
cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal) |
chr15_+_102445367 | 4.38 |
ENSMUST00000023809.4
|
Amhr2
|
anti-Mullerian hormone type 2 receptor |
chr9_-_22002599 | 4.38 |
ENSMUST00000115336.2
ENSMUST00000044926.5 |
Ccdc151
|
coiled-coil domain containing 151 |
chr5_+_92387846 | 4.36 |
ENSMUST00000138687.1
ENSMUST00000124509.1 |
Art3
|
ADP-ribosyltransferase 3 |
chr11_-_58613481 | 4.33 |
ENSMUST00000048801.7
|
2210407C18Rik
|
RIKEN cDNA 2210407C18 gene |
chr7_-_140154712 | 4.32 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr1_+_9547948 | 4.31 |
ENSMUST00000144177.1
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1 |
chr7_-_139582790 | 4.28 |
ENSMUST00000106095.2
|
Nkx6-2
|
NK6 homeobox 2 |
chr1_+_88106834 | 4.27 |
ENSMUST00000113137.1
|
Ugt1a6b
|
UDP glucuronosyltransferase 1 family, polypeptide A6B |
chr7_-_19698206 | 4.22 |
ENSMUST00000172808.1
ENSMUST00000174191.1 |
Apoe
|
apolipoprotein E |
chr5_-_24758008 | 4.20 |
ENSMUST00000047119.4
|
Crygn
|
crystallin, gamma N |
chr7_+_44216456 | 4.19 |
ENSMUST00000074359.2
|
Klk1b5
|
kallikrein 1-related peptidase b5 |
chr11_+_72435534 | 4.18 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr1_-_51915968 | 4.12 |
ENSMUST00000046390.7
|
Myo1b
|
myosin IB |
chr11_-_120661175 | 4.10 |
ENSMUST00000150458.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr7_-_30973367 | 4.06 |
ENSMUST00000108116.3
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr7_-_141010759 | 3.98 |
ENSMUST00000026565.6
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr6_+_72636244 | 3.98 |
ENSMUST00000101278.2
|
Gm15401
|
predicted gene 15401 |
chr11_+_75510077 | 3.97 |
ENSMUST00000042972.6
|
Rilp
|
Rab interacting lysosomal protein |
chr10_+_80329953 | 3.96 |
ENSMUST00000105358.1
ENSMUST00000105357.1 ENSMUST00000105354.1 ENSMUST00000105355.1 |
Reep6
|
receptor accessory protein 6 |
chr10_+_87859255 | 3.96 |
ENSMUST00000105300.2
|
Igf1
|
insulin-like growth factor 1 |
chr9_-_51963533 | 3.95 |
ENSMUST00000034552.6
|
Fdx1
|
ferredoxin 1 |
chr10_+_87521954 | 3.93 |
ENSMUST00000143624.1
|
Pah
|
phenylalanine hydroxylase |
chr19_-_8218832 | 3.93 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr2_-_25470031 | 3.92 |
ENSMUST00000114251.1
|
Ptgds
|
prostaglandin D2 synthase (brain) |
chr2_-_27247260 | 3.91 |
ENSMUST00000102886.3
ENSMUST00000129975.1 |
Sardh
|
sarcosine dehydrogenase |
chr6_+_42245907 | 3.88 |
ENSMUST00000031897.5
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr2_+_105224314 | 3.86 |
ENSMUST00000068813.2
|
0610012H03Rik
|
RIKEN cDNA 0610012H03 gene |
chr16_+_5007283 | 3.85 |
ENSMUST00000184439.1
|
Smim22
|
small integral membrane protein 22 |
chr11_-_116198701 | 3.82 |
ENSMUST00000072948.4
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr3_+_135281221 | 3.82 |
ENSMUST00000120397.1
ENSMUST00000171974.1 ENSMUST00000029817.7 |
Bdh2
|
3-hydroxybutyrate dehydrogenase, type 2 |
chr7_+_140845562 | 3.81 |
ENSMUST00000035300.5
|
Scgb1c1
|
secretoglobin, family 1C, member 1 |
chr7_-_14492926 | 3.80 |
ENSMUST00000108524.3
|
Sult2a7
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 7 |
chr19_-_46672883 | 3.79 |
ENSMUST00000026012.7
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr2_+_102659213 | 3.79 |
ENSMUST00000111213.1
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr15_+_7129557 | 3.77 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr7_-_132576372 | 3.77 |
ENSMUST00000084500.6
|
Oat
|
ornithine aminotransferase |
chr11_-_77519186 | 3.75 |
ENSMUST00000100807.2
|
Gm10392
|
predicted gene 10392 |
chr2_+_58755177 | 3.75 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr9_-_21989427 | 3.68 |
ENSMUST00000045726.6
|
Rgl3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr9_+_107340593 | 3.66 |
ENSMUST00000042581.2
|
6430571L13Rik
|
RIKEN cDNA 6430571L13 gene |
chr17_-_56005566 | 3.65 |
ENSMUST00000043785.6
|
Stap2
|
signal transducing adaptor family member 2 |
chr9_+_44107268 | 3.65 |
ENSMUST00000114821.2
ENSMUST00000114818.2 |
C1qtnf5
|
C1q and tumor necrosis factor related protein 5 |
chr10_+_62071014 | 3.64 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr19_+_39992424 | 3.64 |
ENSMUST00000049178.2
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr8_+_119437118 | 3.63 |
ENSMUST00000152420.1
ENSMUST00000098365.3 |
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr10_+_61720592 | 3.60 |
ENSMUST00000080099.5
|
Aifm2
|
apoptosis-inducing factor, mitochondrion-associated 2 |
chr9_+_123150941 | 3.59 |
ENSMUST00000026890.4
|
Clec3b
|
C-type lectin domain family 3, member b |
chr5_-_113081579 | 3.57 |
ENSMUST00000131708.1
ENSMUST00000117143.1 ENSMUST00000119627.1 |
Crybb3
|
crystallin, beta B3 |
chr4_-_41503046 | 3.56 |
ENSMUST00000054920.4
|
AI464131
|
expressed sequence AI464131 |
chr6_-_124917939 | 3.56 |
ENSMUST00000032216.6
|
Ptms
|
parathymosin |
chr4_-_137409777 | 3.55 |
ENSMUST00000024200.6
|
Gm13011
|
predicted gene 13011 |
chr11_+_101367542 | 3.54 |
ENSMUST00000019469.2
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr10_+_128194446 | 3.53 |
ENSMUST00000044776.6
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr2_+_68104671 | 3.53 |
ENSMUST00000042456.3
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr11_-_5950018 | 3.51 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr1_+_88166004 | 3.51 |
ENSMUST00000097659.4
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr7_-_30973399 | 3.48 |
ENSMUST00000098553.4
ENSMUST00000147431.1 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr5_-_87424201 | 3.47 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr15_-_34495180 | 3.46 |
ENSMUST00000022946.5
|
Hrsp12
|
heat-responsive protein 12 |
chr12_-_103773592 | 3.45 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr6_+_72598475 | 3.44 |
ENSMUST00000070597.6
ENSMUST00000176364.1 ENSMUST00000176168.1 |
Retsat
|
retinol saturase (all trans retinol 13,14 reductase) |
chr9_+_108080436 | 3.44 |
ENSMUST00000035211.7
ENSMUST00000162886.1 |
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr11_+_60728398 | 3.43 |
ENSMUST00000018743.4
|
Mief2
|
mitochondrial elongation factor 2 |
chr8_-_45333189 | 3.43 |
ENSMUST00000095328.4
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3 |
chr4_-_137430517 | 3.42 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr7_+_44384098 | 3.41 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.9 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
5.1 | 20.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
4.9 | 14.6 | GO:0009073 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
4.1 | 12.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.7 | 14.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.4 | 20.6 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
3.2 | 12.7 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
3.0 | 9.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.6 | 7.8 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
2.6 | 12.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
2.4 | 38.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.3 | 16.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
2.3 | 6.8 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
2.2 | 13.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.1 | 2.1 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
2.1 | 6.3 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
2.1 | 4.1 | GO:0006507 | GPI anchor release(GO:0006507) |
2.0 | 6.0 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
2.0 | 9.8 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.9 | 5.8 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.9 | 15.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.9 | 11.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.8 | 25.8 | GO:0015747 | urate transport(GO:0015747) |
1.6 | 4.9 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
1.6 | 14.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.6 | 8.0 | GO:0015886 | heme transport(GO:0015886) |
1.6 | 4.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.6 | 4.7 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
1.6 | 1.6 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
1.5 | 4.6 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.5 | 10.8 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
1.5 | 4.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.5 | 4.6 | GO:1903918 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
1.4 | 5.8 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.4 | 4.2 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
1.4 | 2.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.4 | 1.4 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
1.4 | 9.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.4 | 13.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
1.3 | 4.0 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
1.3 | 4.0 | GO:0015755 | fructose transport(GO:0015755) |
1.3 | 10.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.3 | 3.9 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.3 | 7.7 | GO:0008355 | olfactory learning(GO:0008355) |
1.3 | 6.4 | GO:1904970 | brush border assembly(GO:1904970) |
1.3 | 8.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
1.2 | 1.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.2 | 1.2 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
1.2 | 4.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.1 | 4.6 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.1 | 4.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.1 | 12.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.1 | 2.2 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 6.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.1 | 5.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.1 | 14.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
1.0 | 6.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.0 | 3.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.0 | 7.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.0 | 2.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
1.0 | 4.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.0 | 5.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.0 | 1.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.0 | 2.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.0 | 2.9 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
1.0 | 2.9 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.9 | 20.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.9 | 5.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.9 | 1.8 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.9 | 8.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.9 | 3.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.9 | 5.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.9 | 2.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.9 | 3.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 9.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 2.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 2.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.8 | 9.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.8 | 5.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.8 | 2.4 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.8 | 2.4 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.8 | 4.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.8 | 3.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.8 | 4.8 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.8 | 4.8 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.8 | 7.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.8 | 7.9 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.8 | 4.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 3.1 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.8 | 6.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.8 | 0.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 1.5 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.8 | 2.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.8 | 3.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.8 | 5.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 3.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 3.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.8 | 2.3 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.7 | 2.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.7 | 2.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.7 | 4.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.7 | 3.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.7 | 9.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 18.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.7 | 1.4 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.7 | 3.5 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 2.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 4.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 16.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.7 | 2.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.7 | 4.1 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.7 | 2.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.7 | 2.7 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 2.7 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.7 | 2.7 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.7 | 2.0 | GO:0042091 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.7 | 2.0 | GO:1900245 | negative regulation of MDA-5 signaling pathway(GO:0039534) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 1.9 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.6 | 1.9 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
0.6 | 3.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.6 | 4.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 3.2 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.6 | 1.9 | GO:0070949 | neutrophil mediated killing of fungus(GO:0070947) regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.6 | 6.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.6 | 3.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.6 | 2.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 2.5 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.6 | 4.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.6 | 4.3 | GO:0021539 | subthalamus development(GO:0021539) |
0.6 | 5.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.6 | 7.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 2.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.6 | 3.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 2.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.6 | 1.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 5.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.6 | 2.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.6 | 1.7 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.6 | 1.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.6 | 1.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.6 | 2.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.5 | 2.2 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 4.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.5 | 4.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 1.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.5 | 2.2 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.5 | 1.6 | GO:0061193 | taste bud development(GO:0061193) |
0.5 | 3.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 1.1 | GO:0097325 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) melanocyte proliferation(GO:0097325) |
0.5 | 1.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 1.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 3.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.5 | 3.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 2.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 19.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 2.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 3.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 24.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 2.0 | GO:0006068 | ethanol catabolic process(GO:0006068) ethanol oxidation(GO:0006069) formaldehyde catabolic process(GO:0046294) |
0.5 | 2.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 1.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 2.5 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.5 | 2.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.5 | 2.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 2.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 1.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 3.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 3.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 1.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.5 | 2.8 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 1.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.5 | 1.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 3.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 3.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 2.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 1.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.4 | 1.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.4 | 2.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 1.8 | GO:0060448 | neuropeptide catabolic process(GO:0010813) dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.4 | 1.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 2.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.4 | 4.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 1.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 3.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.4 | 6.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.4 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 3.0 | GO:0015862 | uridine transport(GO:0015862) |
0.4 | 1.3 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.4 | 3.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 4.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 17.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 1.2 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 2.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 3.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 1.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 1.2 | GO:0090285 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.4 | 1.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 0.8 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 3.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 1.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 6.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 2.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 1.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 2.2 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.4 | 2.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 1.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.4 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 1.8 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.1 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.4 | 1.8 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.4 | 1.8 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.4 | 2.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 2.1 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.4 | 1.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 1.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 3.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 22.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 1.0 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.3 | 1.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.3 | 2.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 2.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 4.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 1.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.0 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.3 | 2.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 3.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.3 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.3 | 1.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 4.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 7.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.3 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.9 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.3 | 1.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 5.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.9 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.3 | 1.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 1.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 1.2 | GO:0021660 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.3 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 2.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.9 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.3 | 0.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 3.3 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 1.2 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.3 | 0.9 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 2.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.9 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.3 | 1.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 1.2 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 0.6 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.3 | 1.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.3 | 1.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 3.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 1.1 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.8 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.3 | 0.8 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 1.9 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 4.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.8 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.3 | 2.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.3 | 1.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 3.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.3 | 0.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.3 | 1.1 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.3 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 0.8 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 2.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.8 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 3.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.8 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.3 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 3.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 2.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.3 | 1.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 4.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.2 | 2.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 3.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 2.7 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 3.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 9.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 6.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 2.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.0 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 3.1 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 0.9 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.2 | 0.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 1.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 1.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 1.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 2.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 2.3 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.5 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.2 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 2.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 3.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 7.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.7 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.2 | 1.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.9 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 2.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.8 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 2.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 1.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 1.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.6 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.2 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 2.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 3.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 4.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 1.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.6 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 5.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.8 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 1.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.2 | 3.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 4.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 1.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 2.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 1.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 1.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 2.6 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 2.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 2.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 0.7 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.2 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.4 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.5 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.2 | 1.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 2.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 1.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 2.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 2.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 4.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 2.3 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.2 | 1.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 1.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.2 | 0.9 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 2.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.3 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 2.7 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 2.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.8 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 1.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.8 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 1.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 0.6 | GO:0051311 | male meiosis chromosome segregation(GO:0007060) positive regulation of isotype switching to IgA isotypes(GO:0048298) meiotic metaphase plate congression(GO:0051311) |
0.2 | 3.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 6.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 1.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 2.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.8 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 0.3 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.2 | 1.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 1.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:1902460 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.6 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.1 | 0.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 4.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.6 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.6 | GO:1904426 | positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 | 2.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 2.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 7.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 3.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 2.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 2.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 3.2 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.6 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.7 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 4.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 2.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 3.2 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 1.7 | GO:0072010 | glomerular epithelium development(GO:0072010) |
0.1 | 0.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.8 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.1 | 1.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 1.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 1.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 1.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 9.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 2.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.4 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.1 | 0.5 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 8.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 1.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 1.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 1.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 0.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.9 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 4.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 1.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 2.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.4 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 1.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.4 | GO:0060800 | astrocyte fate commitment(GO:0060018) regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.9 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 3.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.7 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.2 | GO:1905024 | regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
0.1 | 3.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 1.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 6.9 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.6 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 1.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 1.1 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 2.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:1904956 | Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.1 | 0.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 1.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 1.0 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 2.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.3 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.4 |